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From the
President

Colleagues:
April is here and with it Springtime. As I sit
writing this today the weather is beautiful, and
it appears that Spring is really approaching. I
hope you've all had a good month of March.
I'm sure that all of you share with me in
expressing our deep and heartfelt
condolences and sympathy to Ed and Pat
Mullin and their family upon the recent death
of their daughter, Susan. Susan died
suddenly on March 16 after a long battle with
cystic fibrosis.
My first Medical Staff meeting as your
President on March 8, 1999 was held at the
Banko Center on the Muhlenberg Hospital
Center campus. The meeting was well
attended. In addition to the usual agenda
items, Dr. Greg Harper made a presentation
about the vision and goals of the John &
Dorothy Morgan Cancer Center. This
presentation was well received and numerous
important questions were addressed to Greg.
John Haney and Dr. Robert Murphy made a
presentation at the meeting about compliance
related to billing and the Federal
Government's initiative to investigate private
physicians' office billing practices to detect
Medicare fraud and abuse. There are serious
implications for all physicians relative to this
matter. We all need to be sensitive to these
issues and be very careful in our billing
(Continued on Page 2)
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(Continued from Page 1)
practices to insure that we are in compliance with Medicare
guidelines. A documented process needs to be outlined in
each practice office to deal with billing errors and
complaints. John Haney and Lehigh Valley Physician
Business Services has already provided a seminar to help
physicians and their office staffs deal with and understand
these issues. This seminar will be repeated in the:Fall.
Any physicians, office managers, or billing personnel
interested in a future seminar should contact Lehigh Valley
Physician Business Services at (610) 317-4440.
Dr. John Jaffe, co-chair of the Care Management Council,
made a presentation updating the members of the medical
staff about the activities of the Care Management Council
and plans for the reorganized Care Management
Committee. I have asked either John or Bob Laskowski
(the other co-chair) to make a report to the Medical
Executive Committee each month. I will also ask one of
them to make a brief presentation at each of the quarterly
General Medical Staff meetings. There are many care
management issues which need to be addressed by each
of us in our daily practices both in and outside the hospital.
How can we provide the highest level of quality care for our
patients more efficiently, at a lower cost, and in a shorter
length of time? Our nursing colleagues have been
particularly stressed over the last few months as the
hospital has been extremely busy. Much of the stress they
feel is related to the things we ask them to do for our
patients. Remember, we need to think about ways in which
we can "take work out of the system" every day. Is the
result of the lab test or x-ray study which I am ordering
really going to change the way I manage this patient? If
the answer is "No", don't order the test. Does what I am
doing for my patient today require that he or she be in the
hospital, or could the patient receive the same care in
some other setting which would be less expensive, just as
effective, and perhaps even more satisfying for the patient?
If inpatient care isn't required, ask the discharge planner to
help get the patient into whatever setting seems more
appropriate.
Speaking of our nursing colleagues, I'd like to personally
thank them for their outstanding service to our patients over
the past several months when the hospital has been
stressed by high census, bed shortages, and rapid patient
turnover. We appreciate your tireless efforts as well as
those of the technical, support, and administrative partners
in providing high quality, compassionate care to our
patients through a very difficult period. As we make our
rounds on the hospital floors, we all need to remember to
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thank our nursing colleagues for their tremendous help.
"Thanks again."

(
On March 10, I chaired a Medical Staff/Administrative
exchange session held to address issues related to the
operation of the operating rooms at Lehigh Valley Hospital,
Cedar Crest & 1-78. A large group of interested surgeons
attended this meeting and offered a number of excellent
suggestions. Drs. Chuck Hoover and Mark Lester, and Mr.
Lou Liebhaber (COO), described the plans which are
underway to improve the functioning of the operating
rooms, answered questions, and listened to suggestions. I
believe that this meeting was useful and, hopefully as a
result, some immediate actions will be taken to improve the
overall efficiency of the functioning of the operating rooms.
I've recently met with Ed Meehan, MPH, Executive
Director, and Courtney J. Brown, MPH, Program Officer,
from the Dorothy Rider Pool Health Care Trust. The Pool
Trust is anxious to provide funding grants for projects which
will improve the general health of the Lehigh Valley
community. They have asked me to encourage interested
members of the Medical Staff who have ideas for
interesting proposals to contact Courtney at (610) 770-9346
to discuss their ideas. Administrative help is available to
develop grant request proposals. I have asked Ed to corto the June General Medical Staff Meeting to make a (
presentation about the Pool Trust, and to again remind the
Medical Staff that Mr. Pool set aside a great deal of money
to fund projects for the improvement of the health of our
community. I'm sure that many of us can think of some
project which would qualify for this laudable goal and is
only in need of adequate funding. The message is that
there is funding available; we just need to ask for it.
Remember to appoint someone from your office as your
"surrogate" to read your e-mail, if you aren't a regular user
of e-mail. Also remember when you round daily on your
hospital patients to: S.A.T. ("Sit, Ask/Answer, and
Touch").
In closing, Winston Churchill advises that the one duty and
one course is to try to be right. I can't promise that I will
always be right, but I will try, and I will try to do the right
thing for our Medical Staff.

&~

David M. Caccese, MD
Medical Staff President
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At-Large Members Needed for LVH
Medical Executive Committee
The Lehigh Valley Hospital Medical Staff Nominating
Committee is soliciting nominations for five at-large seats,
one of which should be a representative whose primary
clinical practice is based at the Muhlenberg Hospital Center
campus. These at-large seats on the Medical Executive
Committee will be held for a three-year term beginning July
1' 1999.

HCFA has also emphasized that, in the current
environment, prepayment audits would not be discontinued
and that review by physicians only was not an option that it
would consider. They also emphasized that their focus
was not on one-level disagreements in coping. The AMA
has advocated that, given HCFA's focus on differences of
more than one level, the guidelines should not be designed
with higher precision than needed by reviewers to fair1y
assess the level of service provided.

If you have any questions regarding this issue, please
contact Dr. Mullin or Mr. Hart at 402-8980.

Based on the fact that HCFA would not rule out counting,
and after many hours of careful consideration and
consultation with leaders of organized medicine, the Board
concluded that physicians would be best served if it asked
the AMA's CPT Editorial Panel to resume work with HCFA
on the E&M documentation guidelines in order to minimize
physicians' documentation burden, even though HCFA will
not eliminate counting. This participation is premised on
the understanding that any resulting documentation
guidelines will be HCFA's guidelines.

Washington!AMA Update

As it resumes work on the guidelines, the CPT Editorial
Panel has been asked to focus on efforts:

Nominations should be submitted in writing to Edward M.
Mullin, Jr., MD, Chainnan of the Nominating Committee, via
the Medical Staff Services Office, Cedar Crest & 1-78, or
verbally to John W. Hart, Vice President. All nominations
must be submitted by Friday, April30, 1999.

The political heat is, once again, being turned up on
( medicine in Washington. Faced with the prospect of saving
.. Medicare and the Social Security system in a political
climate that will not tolerate increasing the burden of
taxpayers, the political leadership in our nation's capital is
attempting to find ways to generate new dollars. Their
strategy is a two-pronged attack on physicians in this
country.
1) Cut cost. The simple solution is to pay fewer dollars to
those who provide medical care. In 1997, the Heatth Care
Financing Administration (HCFA) adopted new Evaluation
and Management (E&M) guidelines. This policy assigned
levels of care, and thus reimbursement, to a "counting"
system in which an increasing number of systems would be
required to be examined and documented to qualify for a
higher level of care. Furthermore, physicians whose
practices were deemed to be non-compliant with these
guidelines would be considered potential guilty of criminal
fraud and abuse. The AMA was able to delay institution of
these guidelines from the proposed date of July 1, 1998.

(
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HCFA has recently informed the AMA that, although it is
willing to work together with the AMA and its CPT Editorial
Panel to minimize counting requirements and to otherwise
simplify and improve the guidelines, some degree of
"counting" is necessary to achieve consistency of Medicare
carrier enforcement policies.

•
•

to ensure that any guidelines are as consistent as
possible with CPT definitions; and
to diminish the role of "counting" in any guidelines to
the greatest degree possible.

The AMA has continued to work with HCFA and the
Federation on other important AMA policies from A-98 in
areas such as fraud and abuse, confidentiality, medical
review, working with state medical associations to pilot
peer review approaches to E&M services, the need to
obtain informed consent on release of medical records, and
physician education.
The AMA does not expect that any resulting guidelines will
be implemented by HCFA before late in 1999 at the
ear1iest. In the meantime, physicians must also keep in
mind that HCFA's current policy requires physicians to
comply with either the 1995 documentation guidelines or
the 1997 version.
2) Increase income. If the Federal Government can't get
money from the taxpayers, they are going to try to get it
from the doctors. Many of you will recall the penalties paid
by large teaching hospitals in Philadelphia to the
government related to disputed billing practices. This
proved to be such a windfall for the government that it
decided to extend this approach to the physicians
(Continued on Page 4)

HedimiStaff Progress Notes

Page4

April, 1999 • Volume 11, NumiJer 4
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themselves. The Federal Government has, therefore,
budgeted $500 million over the next five years for a
program which will empower the Office of the Inspector
General (OIG) to hire additional inspectors whose sole
purpose will be to invade doctors' offices to examine
patient and financial records so that deviations from
governmental interpretations can be documented and
fines assessed. In the few months that this program has
existed, fines levied against physician practices have
been as high as $500,000 to $1 ,000,000!
So, I appeal to each and every one of my physician
colleagues to begin to prepare for this onslaught. With
regard to new E&M guidelines, stand ready to heed any
call to action made by the AMA in the months to come.
When faced with this new initiative by the OIG, we must
be more proactive and prepared. I urge every one of us
to establish an office compliance program and make
ready for the invasion of the Visigoths.
Perhaps in no other more immediate way can value be
seen in being members of our GLVIPA and PHO than in
a service which is being offered that can help us meet
this onslaught. Mr. John Haney, Executive Director,
Lehigh Valley Physician Business Services (LVPBS), is
offering, through the MSO, courses and consultation.
LVPBS can assist you and your staff in creating a
compliance program that ensures the practice's intent
and commitment to comply with all Medicare, Medicaid,
and managed care rules. Developing a voluntary plan
will help avoid prosecution, discourage wrongdoing, and
detect problems before they escalate out of control. For
more information, please contact Mr. Haney at (610)
317-4441.

Rapid HIV Test
Effective March 9, Rapid HIV Tests will be utilized wht.,
a healthcare worker has a significant occupational
exposure to a patient's blood or body fluids. Rapid
resulting of both the healthcare worker's and the source
patient's HIV status will assist in providing appropriate
post-exposure management, which is an important
element of workplace safety.
If a source patient is HIV positive, post-exposure
prophylaxis (one or more medications) may be helpful in
preventing the transmission of the HIV virus to the
exposed healthcare worker. The medication should be
started within hours of the exposure. In order to take
advantage of the rapid testing, it is crucial that any
health care worker who experiences a blood or body
fluid exposure report the exposure immediately to
Employee Health Services during business hours
(Monday through Friday, 7:30 a.m. to 4 p.m.). If an
exposure occurs evenings or nights, holidays or
weekends, the exposed healthcare worker should
report directly to the Emergency Department with
his/her incident report.

J. .

Please take advantage of this new technology which
result in improved post-exposure management by
reporting and responding urgently when you are exposed
to blood and/or body fluids.
If you have any questions about the procedure, please
call Employee Health Services at 402-8869, page the
Employee Health nurse on call via the page operator
(402-8999), or call the Needlestick Hotline at 402-STIK.

Please, be prepared!

LOVAR Study News
Robert X. Murphy, Jr., MD
OMSS Representative
Lehigh Valley Hospital

Pertinent study information, containing
inclusion and exclusion criteria, is available to
physicians in a quick reference brochure
format.
For your own personal copy, please call the
LOVAR office at (61 0) 402-4088.
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Physician Assistance Program
(

The Medical Staff of Lehigh Valley Hospital recognizes that
a wide range of problems in life can affect a physician's
health and well-being, and, at times, professional
performance.
In fact, studies conducted by the National Institute for
Occupational Health and Safety report that physicians,
along with other caregivers, may have a higher than
average risk of developing debilitating personal problems.
Since 1993, the Physician Assistance Program has been
available to help members of the Medical Staff deal with
personal problems before they affect health, family life, or
professional effectiveness.
The Physician Assistance Program is a confidential (and if
so desired, anonymous), professional counseling and
referral service available to active members of the Medical
Staff of Lehigh Valley Hospital and their dependents.

(

This service is provided through an agreement with
Preferred EAP which operates the Lehigh Valley Hospital's
Employee Assistance Program (EAP) and has been
involved with over 3,000 employees and dependents since
1985.
The Physician Assistance Program offers physicians and
their families counseling services for a wide range of
personal-problems - anything that can tum stress into
distress - including marital or relationship difficulties;
depression and anxiety; alcohol or drug abuse; family
problems, or stress from work or personal concerns.
Program users can choose from a multi-disciplinary team
assembled to provide Physician Assistance Program
services. This team includes:
0

Michael W. Kaufmann, MD, Chairperson, Department
of Psychiatry
0 John C. Turoczi, EdD, licensed psychologist and
member of the Allied Health Professional Staff of
Lehigh Valley Hospital
0 Staff of Preferred EAP including licensed social
workers, masters level clinicians, and certified
addiction counselors.
To use the Physician Assistance Program during normal
working hours, telephone the Preferred EAP office at (610)
433-8550 or 1-800-327-8878, identify yourself ONLY as a
member of the Lehigh Valley Hospital's Medical Staff (or a
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family member), and ask to speak to the Program Manager,
Robin Chase. Please note that callers may remain
anonymous.
Ms. Chase, or the Preferred EAP receptionist, will conduct
a brief telephone interview, offer a choice among the above
listed provider team members, and advise the caller how to
arrange an appointment.
Other professional staff of Preferred EAP are available after
hours to respond to emergency situations.
The number of visits will vary with the nature and severity
of the problem. Up to five visits with Physician Assistance
Program providers are available to active Medical Staff
members (and their dependents) at no cost.
If their is a need for further service or treatment, a referral
may be made to a private practitioner or community
resource, or the user may continue with the original
Physician Assistance Program provider on a self-pay basis.
For more information, contact Robin Chase at Preferred
EAP at 433-8550, or John W. Hart, Vice President, in
Medical Staff Services, at 402-8980, or any member of
TROIKA.

A Message from the
Eastern Pennsylvania
Funeral Directors Association
Due to a changing attitude in today's society,
cremation is becoming more prevalent. Both
Lehigh and Northampton counties require that
the coroner's office be provided with a
completed death certificate before cremation
can take place. In many cases, when death
certificates are not procured immediately,
many families incur added expenses for
embalming or refrigeration of the deceased.
In order to avoid these added expenses for
your patients' families, when at all possible,
please complete death certificates in an timely
manner. Your cooperation is truly
appreciated.
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Coming Soon to a TV Near YouThe Health Channel
The Health Channel provides continuing medical
education {CME) and continuing education {CE)
programming, as well as other health education to the
three million healthcare practitioners in the United
States.
The Center for Educational Development and Support
has arranged for Lehigh Valley Hospital to receive a onemonth trial of TiP-TV during the month of April. TiP-TV
includes The Health Channel (a 24-hour, 7 day per
week, health education channel), Diagnostic Imaging
{the original TiP-TV channel for medical imaging
professionals}, and Focus on Healthcare {covering a
wide range of compelling healthcare topics). The
programming will be delivered through the hospital's
main cable system at Cedar Crest. & 1-78 and 17th &
Chew on Channel26.
The Health Channel keeps healthcare professionals
educated and helps them meet their continuing
education requirements. Fulfilling continuing education
requirements ensures optimal patient care and keeps
healthcare professionals at the forefront of medicine.
Look to The Health Channel for up-to-date expert
presentations, informed roundtable discussions, and
news about medical discoveries, disease management
and treatments.
To learn more about The Health Channel, visit their Web
site at http://www.healthchannelweb.com.

Renal Enhancement Program
James E. Kintzel, MD, Director, Peritoneal Dialysis, has
been the driving force behind the need to provide renal
educational programs to the Lehigh Valley community.
One such program available to patients who have been
newly diagnosed with chronic renal failure is the Renal
Enhancement Program.
The Renal Enhancement Program, a two-part program
offered free of charge to patients and their families,
provides information regarding treatment options,
nutrition, lifestyle changes, and ways to cope.
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The next two-part program will be held on May 17 and
24, from 6 to 8 p.m., in Conference Room 1B of the Jo~n
and Dorothy Morgan Cancer Center. Light refreshme(
will be served.
For more information, please contact Joan Noll in
Peritoneal Dialysis at {610) 402-0600.

News from Nuclear Medicine at
MHC
The Nuclear Medicine Department at Muhlenberg
Hospital Center is pleased to announce an exciting new
imaging method for detecting acute deep venous
thrombosis (DVT).
Acutect (Technetium-99m labeled Apcitide) is a unique,
synthetic peptide radiopharmaceutical indicated for
scintigraphic imaging of acute venous thrombosis in the
lower extremities. This is the first imaging modality to
target acute DVT. Imaging of the lower extremities is
performed both 10 minutes and 60 minutes following
intravenous injection of the radiopharmaceutical.

(

While this technique does not replace ultrasound or
venography, it may be helpful in those patients who have
indeterminate or equivocal sonographic findings, are
technically difficult to scan (e.g., large body habitus),
have an overlying cast, or in those cases where
determining acute {vs. chronic) DVT is of clinical
importance.
If you have any questions regarding this issue or have
patients who would benefit from this study, please
contact Gregg D. Schubach, MD, Director of Nuclear
Medicine (MHC), or Dave Steigerwalt, Nuclear Medicine
supervisor, at (610) 861-2232.

Daylight Savings

Sunday, Apri/4
Don't forget to turn
your clocks ahe~rtl

\
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MHC Phamis Implementation
( Update

At the end of April, Phamis Lastword will be implemented
at Muhlenberg Hospital Center. It will replace the
existing Hospital Information System which is not year
2000 compliant.
Patient related information available on-line regardless of
the facility where the visit occurred includes:

(

•
•
•
•
•
•
•

Demographics
Lab results
Ancillary results (such as Radiology reports)
Transcriptions (H&Ps, Operative Notes, Discharge
Summaries, etc.)
Allergy and Intolerance information
Orders
Medications and IVs

To introduce and prepare physicians for this new system,
education sessions have been scheduled as follows:
•
•
•
•
•
•

Monday, April26- 5:45 to 7:15p.m.
Tuesday, April27- 7 to 8:30a.m.
Tuesday, April 27- Noon to 1:30 p.m.
Wednesday, April 28 - 7 to 8:30 a.m.
Wednesday, April 28 - Noon to 1:30 p.m.
Thursday, April29- 5:45 to 7:15p.m.

All classes will be held in the First Floor Computer
Training Room at Muhlenberg Hospital Center.
Registration for class is requested. To register, please
contact Diane Zapach in Physician Relations at (61 0)
402-9192.
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Affinity's Diabetic Foot and Wou~d
Care Program Receives Generous
Donation
Affinity's Diabetic Foot and Wound Care Program,
directed by Larry N. Merkle, MD, Chief, Division of
Endocrinology/Metabolism, was recently honored to
receive a generous donation from an anonymous donor.
The donor and her husband were successfully treated at
Affinity's wound care program a few years ago, and in
fact, provided their first donation to the program at that
time. The first donation allowed Affinity to purchase a
Gait Analysis System which has been instrumental in the
treatment and prevention of foot ulcers. The most recent
donation will be used in many ways to further enhance
the five year old program, including: a computer/data
collection system for measurement of outcomes, a
Tekscan F-socket to enhance care for blk amputees via
the computerized gait analysis system, an indigent care
fund for those without insurance, and some equipment
upgrades.
The Diabetic Foot and Wound Care Program provides a
multi-disciplinary team approach to wound care. This
team includes endocrinologists, podiatrists, pedorthists,
orthatists, nurse patient educators, and various physical
therapists and physical therapy assistants. The success
of this program and the wonderful treatment the patients
receive is a direct result of the expertise of Affinity's
team.
Affinity's Diabetic Foot and Wound Care Clinic is held on
Mondays from 2 to 5 p.m. at Affinity, 1243 S. Cedar
Crest Blvd., First Floor. For more information, please call
Affinity at 402-9292.

Congratulations/
James T. McNelis, DO, Division of General Internal
Medicine/Geriatrics, was recently elected a Fellow of the
American College of Physicians.
Craig J. Sobolewski, MD, Division of Primary Obstetrics
and Gynecology, was recently notified that he has
fulfilled all necessary requirements and is now a certified
Diplomate of the American Board of Obstetrics and
Gynecology.
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Papers, Publications and
Presentations
George A. Arangio, MD, Associate Chief, Division of
Orthopedic Surgery {LVH}, co-authored the paper,
"Mathematical modeling of support distribution under the
foot,· which was published in Journal of the
Pennsylvania Academy of Science.
Scott Beman, MD, general surgery resident, presented
a poster on "Higher cyclosporine levels decrease kidney
rejection episodes without increasing nephrotoxicity" at
the Eastern Pennsylvania Chapter of the American
College of Surgeons meeting. Co-authors include Craig
R. Reckard, MD, Chief, Section of Transplantation
Surgery; Douglas E. Johnson, MD, Division of
Nephrology; and Thomas E. Wasser, PhD, Director of
Health Studies.
K. Lesley Birmingham, MD, Chief Resident in Plastic
Surgery, presented her paper on "Patterns of pediatric
facial trauma in motor vehicle collisions" at the Joint
Scientific Meeting on Plastic Surgery in London. Coauthors include Robert X. Murphy, Jr., MD, and Walter
J. Okunski, MD, of the Division of Plastic and
Reconstructive Surgery; and Thomas E. Wasser, PhD.
Dr. Birmingham presented the paper as a poster at the
Pennsylvania Committee on Trauma Residents' Trauma
Paper Competition.
Mehrzad Bozorgnia, MD, general surgery resident,
presented his paper, "lnfrainguinal bypass in patients
with end-stage renal disease: Survival and ambulation,"
at the Surgical Forum of the American College of
Surgeons Fall meeting. Co-authors of the paper include
Gary G. Nicholas, MD, Chief, Division of Vascular
Surgery and Program Director of the General Surgery
Residency, Susan A. Nastasee, Surgical Editor, and
James F. Reed Ill, PhD, Department of Community
Health. Dr. Bozorgnia also presented a poster of the
paper at the Eastern Pennsylvania Chapter of the
American College of Surgeons meeting.
Mark D. Cipolla, MD, PhD, Chief, Section ofTrauma
Research and Associate Chief, Division of TraumaSurgical Critical Care, presented the poster, "Soluble
endothelial cell adhesion molecules in patients with
septic shock," at the Association for Academic Surgery.
Co-authors include Kathy Gottlund, Biological Therapy
Lab, Leslie Saga, Trauma Program Development, and
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Michael D. Pasquale, MD, Chief, Division of TraumaSurgical Critical Care. Dr. Cipolle also presented a .
poster on "Long-term follow-up in trauma patients wit~
vena cava filter" at the American Association for the
Surgery of Trauma. His co-authors include Ivy Fearen,
Trauma Program Development, and Dr. Pasquale.
E. James Frick, Jr., MD, Chief Surgical Resident; Linda
L. Lapos, MD, Division of Colon and Rectal Surgery;
and H. David Vargas, MD, former member of the
Division of Colon and Rectal Surgery, co-authored the
paper, "Solitary neurofibroma of the anal canal, • which
will be published in Diseases of the Colon & Rectum.
In addition, Dr. Frick, along with Michael D. Pasquale,
MD, and Mark D. Cipolle, MD, PhD, co-authored the
paper, "Small bowel and mesentery injuries in blunt
trauma," which was accepted for publication in the
Journal of Trauma. Dr. Frick presented the paper as a
poster at the annual meeting of the Society of Critical
Care Medicine.
Dr. Frick also presented "Somatostatinoma of the
ampulla of Vater in celiac sprue" as a poster at the 1999
Americas Hepato-Pancreato-Biliary Congress. Herbert
C. Hoover, Jr., MD, Chairperson, Department of
(
Surgery, was co-author.
·.
Patrick Gonzalez, Jr., MD, resident in surgical critical
care, presented his paper, "Reduction of catheterassociated central line sepsis in a bum unit: A new
method of catheter care," at the Eastern Pennsylvania
Chapter of the American College of Surgeons meeting
and the Pennsylvania Committee on Trauma Residents'
Trauma Paper Competition. Co-authors include Minh Ly
T. Nguyen, MD, Division of Infectious Diseases,
Bernadette Kratzer, RN, and Terry Burger, RN,
Infection Control Department, Elaine Walz, RN, Cancer
Program, and Kevin J. Farrell, MD, Chief, Section of
Bum. Dr. Gonzalez also presented the paper as a
poster at the meeting of the Society of Critical Care
Medicine.
In addition, Dr. Gonzalez presented a poster on "Violent
firearm injuries: A pleas for prevention" at the
Pennsylvania Committee on Trauma Residents' Trauma
Paper Competition. Co-authors include Michael D.
Pasquale, MD, Mark D. Cipolle, MD, PhD, and Judith
M. Schultz, Trauma Development.
(
(Continued on Page 9)

Medical Staff Progress Notes

April, 1999 • Volne ll, Number 4

(Continued from Page 8)

(

Tito Gorski, MD, former colon and rectal surgery
resident; Lester Rosen, MD, Associate Chief, Division of
Colon and Rectal Surgery; Robert D. Riether, MD,
Director, Colon and Rectal Residency Program; John J.
Stasik, MD, Chief, Division of Colon and Rectal Surgery,
and lndru T. Khubchandani, MD, Division of Colon and
Rectal Surgery, co-authored the paper, "Colorectal
cancer after surveillance colonoscopy: False negative
exam or fast growth?", which will be published in
Diseases of the Colon & Rectum.
In addition, Dr. Gorski and Dr. Rosen, along with Susan
Lawrence and Douglas Helfrich of the Department of
Care Management Systems, and James F. Reed Ill,
PhD, Department of Community Health, co-authored the
paper, "Usefulness of a state-legislated, comparative
database to evaluate quality in colorectal surgery,• which
will be published in Diseases of the Colon & Rectum.
Dr. Gorski and Dr. Khubchandani also co-authored the
paper, "Retrorectal carcinoid tumor,• which will be
published in Southern Medical Journal.

(

"Adverse Effects of Outpatient Parenteral Antibiotic
Therapy,• an article authored by Margaret L. HoffmanTerry, MD, Division of Infectious Diseases, was
published in the January 1999 issue of the American
Journal of Medicine.
Herbert C. Hoover, Jr., MD, Chairperson, Department
of Surgery, co-authored the paper
"Radioimmunoscintigraphy of recurrent, metastatic, or
occult colorectal cancer with technetium Tc 99m
88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally
human monoclonal antibody,• which was published in
Diseases of the Colon & Rectum.
Peter A. Keblish, Jr., MD, Chief, Division of Orthopedic
Surgery, was the moderator of a two-day Advanced
Learning Center on Mobile Bearing Total Knee
Arthroplasty, which was held in conjunction with the
American Academy of Orthopaedic Surgeons meeting
held in Anaheim, Calif. Dr. Keblish also presented
several papers on topics of primary and revision total
knee arthroplasty.

(

!n addition, Dr. Keblish authored an article, "The Artificial
Hip," which was published is Doctors Forum. The
article is directed primarily at the general public to
enhance their understanding of total hip replacement.
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Michael T. Kennedy, MD, and Randolph Wojcik, MD,
general surgery residents; Mark D. Cipolle, MD, PhD,
James G. Cushman, MD, Chief, Section of Pediatric
Trauma, and Michael D. Pasquale, MD, co-authored the
paper, "Incorporation of focused assessment for the
sonographic examination of the trauma patient (FAST)
into an algorithm for evaluation of blunt abdominal
trauma: A prospective study," which was presented at
several regional and national meetings, including a
poster presentation at the Society of Critical Care
Medicine, and an oral presentation at the Eastern
Pennsylvania Chapter of the American College of
Surgeons meeting. Dr. Kennedy won an educational
scholarship award for his presentation at the Society of
Critical Care Medicine. In addition, Dr. Kennedy
presented the paper at the Pennsylvania Committee on
Trauma Residents' Trauma Paper competition and the
Region Ill American College of Surgeons Committee on
Trauma Residents' Trauma Paper Competition where he
won first place for both presentations.
Daniel M. Morrison, MD, surgical resident; Michael D.
Pasquale MD, Chief, Division of Trauma-Surgical Critical
Care; and Charles J. Scagliotti, MD, Division of
General Surgery/Trauma-Surgical Critical Care, coauthored the paper, "Hydrostatic rectal injury of a jet ski
passenger: Case report and discussion,· which was
published in the Journal of Trauma.
W. Michael Morrissey, Jr., DMD, MD, plastic surgery
resident, presented his paper, "The increase in TRAM
flap survival after delay does not diminish long-term," at
the Eastern Pennsylvania Chapter of the American
College of Surgeons meeting. Geoffrey G. Hallock,
MD, Associate Chief, Division of Plastic and
Reconstructive Surgery (LVH), was co-author.
Michael D. Pasquale, MD, Chief, Division of TraumaSurgical Critical Care, presented his paper, "Decreased
resource utilization, length of stay, and costs using a
trauma operations improvement team,· at the Society of
Critical Care Medicine meeting. Co-authors include
James G. Cushman, MD, and Kevin E. Glancy, MD,
Division of Trauma-Surgical Critical Care/General
Surgery; Mary Jean Osborne, Director, Open Heart Unit
and Transitional Open Heart Unit; Juliet Fischer,
Trauma Coordinator; Betsy Seislove, Patient Care
Specialist; and Judith M. Schultz, Trauma
Development. Dr. Pasquale also presented a poster,
"Should routine helmet use be required for recreational
skiers?" at the Society of Critical Care Medicine meeting.
(Continued on Page 10)
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In addition, Dr. Pasquale presented his paper, "Outcome
analysis of Levell and Level II trauma centers," at the
American Association for the Surgery of Trauma. Coauthors include Andrew Peitzman, MD, of the University
of Pittsburgh, and Thomas E. Wasser, PhD, Director of
Health Studies. The paper has been submitted to the
Journal of Trauma.
Rovinder "Bob" Sandhu, MD, general surgery resident,
presented a poster on "Measurt::ment of endotracheal
tube cuff leak to predict post-extubation stridor and need
for reintubation" at the Eastern Pennsylvania Chapter of
the American College of Surgeons meeting and the
meeting of the Society of Critical Care Medicine. Coauthors include Michael D. Pasquale, MD, Kenneth
Miller, Respiratory Therapist, and Thomas E. Wasser,
PhD.

Upcoming Seminars,
Conferences and Meetings
Emergency Medicine Grand Rounds
Grand Rounds, sponsored by the Department of
Emergency Medicine, will be held on Thursday, April1,
from 9 a.m. to 1 p.m., in the Emergency Medicine
Institute, 1251 S. Cedar Crest Blvd., Suite 308C.
Topics to be discussed include:
• Carbon Monoxide and Cyanide Poisoning - Gary
Bonfante, DO
• Pediatric Abdominal Pain - Ronald A. Lutz, Sr., MD
For more information, please contact Judy Szep in the
Department of Emergency Medicine at 402-7168.

Medical Grand Rounds
Medical Grand Rounds are held every Tuesday
beginning at noon in Lehigh Valley Hospital's Auditorium
at Cedar Crest &1-78.

•

•
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April 20 - Benefits & Toxicity of Non-Steroidals with •
an Evaluation of the Safety of the new COX II (c
Inhibitors
April27- Medical Ethics are Unethical Public Policy

For more information, please contact Evalene Patten in
the Department of Medicine at 402-1649.

Department of Pediatrics
The Department of Pediatrics conferences are held on
Fridays beginning at noon in Lehigh Valley Hospital's
Auditorium at 17th &Chew.
Topics to be discussed in April include:
•

April 23 - Syncope in Adolescents

For more information, please contact Kelli Ripperger in
the Department of Pediatrics at 402-2540.
"Respiratory and Neurological Challenges for
Today's Children: From Hospital to Home," a twoday conference sponsored by the Department of
Pediatrics, will be held April7 and 8, from 8 a.m. to 4{"
p.m. both days, in the Lehigh Valley Hospital Auditori~•..
at Cedar Crest & 1-78.
The conference is designed for physicians, nurses, nurse
practitioners, and other healthcare providers who
participate in the planning, implementation, evaluation,
and revision of patient care for children with acute and
chronic respiratory and/or neurological illness.
For more information, please contact Kelly Beauchamps
in the Center for Education at 402-1700.

Stahler-Rex Health Care Lecture
Richard Lamm, former Governor of Colorado, will be the
featured speaker at this year's Stahler-Rex Health Care
Lecture scheduled for Tuesday, April 27, beginning at 7
a.m., in the Auditorium at Lehigh Valley Hospital, Cedar
Crest & 1-78. His topic will be "The Brave New World of
Health Care."

Topics to be discussed in April include:

(
•
•

AprilS- Ventricular Tachycardia- What's New?
April13 - Update on Staphylococcal Disease
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Who's New
(

The Who's New section of Medical Staff Progress Notes
contains an update of new appointments, address
changes, status changes, etc. Please remember to update
your directory and rolodexes with this information.

Medical Staff
Gregor M. Hawk, MD

Appointments

Orthopedic Associates of Allentown
1243 S. Cedar Crest Blvd., Suite 2500
Allentown, PA 18103-7982
(610) 433-6045
Fax: (610) 433-3605
Department of Surgery
Division of Orthopedic Surgery
Site of Privileges - LVH & MHC
Provisional Active

Thong P. Le, MD
(Solo Practice)
Pasteur Merieux Connaught
Route 611, P.O. Box 187
Swiftwater, PA 18370
(717) 839-6144
Fax: (717) 839-0934
Department of Medicine
Division of Infectious Diseases
Site of Privileges: MHC
Provisional Associate

Andrea B. Gonzalez-Torrado, MD

(

Children's HealthCare
Children's HealthCare Center
1517 Pond Road
Allentown, PA 18104-2250
(61 0) 395-4444
Fax: (610) 366-7886
Department of Pediatrics
Division of General Pediatrics
Site of Privileges - LVH & MHC
Provisional Active

Richard F. Goy, MD

(

LVPG-Medicine
Trexlertown Convenience Center
6900 Hamilton Blvd.
P.O. Box60
Trexlertown, PA 18087-0127
Department of Medicine
Division of General Internal Medicine
Site of Privileges - LVH & MHC
Provisional Active

Larry Levin, MD
Muhlenberg Primary Care, PC
2597 Schoenersville Road
Suite 302
Bethlehem, PA 18017-7309
(610) 868-6880
Fax: (610) 868-5333
Department of Medicine
Division of General Internal Medicine
Site of Privileges - LVH & MHC
Provisional Active
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Glenn A. Mackin, MD
Lehigh Neurology
1210 S. Cedar Crest Blvd.
Suite 1800
Allentown, PA 18103-6208
(610) 402-8420
Fax: (610) 402-1689
Department of Medicine
Division of Neurology
Site of Privileges· LVH & MHC
Provisional Active

Deborah L Villeneuve, MD
Lehigh Valley Women's Health Care Alliance
1575 Pond Road, Suite 104
Allentown, PA 18104-2250
(610) 398-7848
Fax: (610)398-2220
Department of Obstetrics and Gynecology
Division of Primary Obstetrics and Gynecology
Site of Privileges • LVH & MHC
Provisional Active

Practice Changes
Martin LeBoutillier Ill, MD
(No longer with Panebianco-Yip Heart Surgeons)
The Heart Care Group, PC
1210 S. Cedar Crest Blvd., Suite 2300
Allentown, PA 18103-6286
(610) 437-5505
Fax: (61 0) 437-5763

Sarah L Stevens, MD
LVPG-Medicine
Lehigh Valley Family Health Center
1730 Chew Street
Allentown, PA 18104-5595
(610) 402-3500
Fax: (610) 402-3509
Department of Medicine
Division of General Internal Medicine
Site of Privileges • LVH & MHC
Provisional Active

(

William J. Liaw, DO
(No longer with Primary Care Associates in the LV, PC)
Macungie Medical Group
3261 Route 100
P.O. Box487
Macungie, PA 18062-9389
(61 0) 966-4646
Fax: (610) 965-6201
Theodore G. Phillips, MD
(No longer with Panebianco-Yip Heart Surgeons)
The Heart Care Group, PC
1210 S. Cedar Crest Blvd., Suite 2300
Allentown, PA 18103-6286
(610) 437-5505
Fax: (610) 437-5763
Michael C. Sinclair, MD
(No longer with Panebianco-Yip Heart Surgeons)
The Heart Care Group, PC
1210 S. Cedar Crest Blvd., Suite 2300
Allentown, PA 18103-6286
(610) 437-5505
Fax: (610) 437-5763

{
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Raymond L. Singer, MD
(No longer with Panebianco-Yip Heart Surgeons)
The Heart Care Group, PC
1210 S. Cedar Crest Blvd., Suite 2300
Allentown, PA 18103-6286

(610) 437-5505
Fax: (610) 437-5763

John B. Paulus, DO
Allentown Internal Medicine, Ltd.
2895 Hamilton Blvd., Suite 101
Allentown, PA 18104-6192

Appointments

Albert J. Peters, DO

Allentown MedicaJ.Center
401 N. 17th Street, Suite 312
Allentown, PA 18104-5104

(61 0) 402-9522
Fax: (610) 402-9649

New Fax Number
Primary Care-Associates in the LV, PC
-Shawn R. Ruth, DO
- David M. Stein, DO
New Fax: (610) 776-6344

Status Changes
Frank J. Altomare, Jr., MD
Department of Radiology/Diagnostic Medical Imaging
Division of Nuclear Medicine
From Active to Emeritus Active
Matthew A. Kasprenski, Sr., MD
Department of Family Practice
From Affiliate to Emeritus Affiliate
E. Brian Petrasek, MD
Department of Family Practice
From Provisional Active to Provisional Affiliate
John F. Pifer, DO
Department of Family Practice
From Affiliate to Emeritus Affiliate

(

William E. Tucker, MD
Department of Emergency Medicine
Division of Emergency Medicine
Provisional Active

Allied Health Professionals

(61 0) 776-6666

Christopher Stella, MD
From: Department of Medicine
Section: House
Category: Active
To: Department of Emergency Medicine
Division of Emergency Medicine
Category: Limited Duty
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Resignation

Address Changes

Fax: (610) 776-0179

(
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Dena L. Capobianco, PA
Physician Extender
Physician Assistant- PA
(Gastroenterology Associates Ltd. - Michael H. Ufberg, MD)
Alice Gallagher, CRNP
Physician Extender
Professional - CRNP
(John J. Cassel, MD, PC -John J. Cassel, MD)
Karen A. Moffat, RN
Physician Extender
Professional- RN
(Yeisley Cardiothoracic Surgery, LLC- Geary L. Yeisley, MD)
Anthony J. Pack, PA·C
Physician Extender
Physician Assistant- PA-C
(The Heart Care Group, PC - Theodore G. Phillips, MD)
Donna F. Petrucelli, CRNP
Physician Extender
Professional- CRNP
(The Heart Care Group, PC - James A. Sandberg, MD)
Doris M. Vasko
Physician Extender
Technical- Medical Assistant
(ABC Family Pediatricians • Donald L. Levick, MD)

Changes of Supervising Physician
David A. Cederberg
Physician Extender
Technical- Surgical Technician
From: Antonio C. Panebianco, MD- Panebianco-Yip Heart
Surgeons and Geary L. Yeisley, MD- Yeisley Cardiothoracic
Surgery, LLC
To: Geary L. Yeisley, MD- Yeisley Cardiothoracic Surgery, LLC
Lee E. Speed, PA·C
Physician Extender
Physician Assistant- PA-C
From: Theodore G. Phillips, MD
To: Michael C. Sinclair, MD- The Heart Care Group, PC
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George M. Walton, PA.C
Physician Extender
Physician Assistant - PA-C
From: Antonio C. Panebianco, MD- Panebianco-Yip Heart
SUrgeons
To: Michael C. Sinclair, MD- The Heart Care Group, PC

(

Resignations
Barbara M. Enger, RN
Physician Extender
Professional - RN
(David L Schwendeman, MD)
Claudette M. Geist
Physician Extender
Technical- SUrgical Technician
(Lehigh Eye Specialists, PC - Masayuki Kazahaya, MD)

(

(
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HOSPITAL

(

THERAPEUTICS AT A GLANCE
The followina actions were taken at the January/February 1999 Therapeutics Committee Meeting - Rebecca Hockman,
Pharm.D., BCPS, Christopher Moore, R.Ph., Joseph Ottinger, R.Ph., MS, MBA

ENOXPARIN FOR
UNSTABLE ANGINA
Two recent trials (ESSENCE AND TIM!
llb) involving enoxaparin and aspirin vs
UFH (unfractionated heparin)· and aspirin
in the treatment of unstable angina were
presented at the February Therapeutics
Committee meeting. Both studies
appeared to support the use of the LMWH
(low molecular weight heparin) product
arm. Their was a statistically significant
relative risk reduction (RRR) in the
respective triple end points of both studies
(death, MI, and recurrent angina in
ESSENCE; death, Ml, and the need for
urgent revascularization in TIMI 11 b) in
comparison with the UFH arm.

(

(

However, there was some concern about
aspects of the two studies and their
analysis that should be noted. The
importance of adequate anticoagulation has
been recognized in studies of agents touted
as replacements for UFH. The use of
empirical dosing of IV UFH has been
shown to produce inadequate levels of
anticoagulation. The empirical dosing
protocol used in the ESSENCE trials
resulted in less than half of the patients
treated with UFH achieving an aPTT in
the target range by 24 hours. Certainly
this may have biased the results in favor of
enoxaparin. Secondly, the importance of
achieving a single targeted aPTT has been
frequently questioned. This may be
related to the need for each institution with
different equipment, personnel and
thromboplastin reagents for aPTT tests to
establish its own UFH sensitivity curve.
The guidelines of the American College of

Chest Physicians currently recommend that
the goal for UFH therapy should
correspond to a blood concentration of
0.2-0.4 units/mi. Therefore, as with
warfarin monitoring prior to use of the
INR, therapeutic heparin monitoring via
the use of aPTT can be deceiving. Both
the ESSENCE and TIM! llb trials utilized
multiple institutions (176 and 200,
respectively) and were carried out in 10
countries. One must at least consider that
so many disparate institutions did not have
identical sensitivity curves which could
have affected the observed outcomes.
Finally, although the triple end points were
statistically significant, the individual end
. points of death, MI and revascularizationl
recurrent angina did not achieve statistical
significance in the ESSENCE trial. The
highest positively correlated data involved
recurrent angina. Death and MI trended
toward the LMWH treatment arm, but
were not statistically significant. Recently,
the Fifth ACCP Consensus Conference on
Antithrombotic Therapy gave the use of
LMWH for unstable angina an A2
recommendation (Methods strong, results
consistent, effect equivocal-uncertainty
whether benefits outweigh the risks).
Currently, a bag of unfractionated heparin
costs $2.85 each, while an aPTT test costs
@$3.50 each. The ctaily drug acquisition
cost for enoxaparin in a 70 kg individual
would be $62.00 at the recommended dose
of lmg/kg every 12 hoilrs. The average
treatment duration was a little less than 3
days in the ESSENCE trial with a range of
2-8 days. Treatment with aspirin was
continued in all the studies after the
LMWH was stopped.
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EMESIS NEMESIS
Dolasetron injectable (Anzemet) is
indicated for the prevention and treatment
of postoperative nausea and vomiting. At
higher doses this agent can also be utilized
to prevent nausea and vomiting associated
with initial and repeated courses of
moderately emetogenic chemotherapy.
However, a review of this indicated use
was not pursued at this time.
Dolasetron is a potent, selective and
reversible 5-HT3 receptor antagonist. Its
clinical activity appears to be due to its
reduced metabolite, hydrodolasetron,
which is 50 to 100 times more potent than
dolasetron.
For the prevention of postoperative nausea
and vomiting, the recommended adult
intravenous dose is 12.5 mg given as a
single dose approximately 15 minutes
before the cessation of anesthesia. The
same dose may be administered for the
treatment of post-operative nausea and
vomiting, administered as soon as nausea
or vomiting occurs. In pediatric patients,
2 to 16 years of age, the recommended
intravenous dose is 0.35 mg/kg, up to a
maximum dose of 12.5 mg, given as a
single dose approximately 15 minutes
before the cessation of anesthesia or as
soon as nausea or von;:riting occurs.

CONCLUSION: Dolasetron offers an
alternative to ondansetron (Zofran) and
granisetron (Kytril) in the prevention of
nausea and vomiting, although no
advantages over these agents have been
demonstrated. Dolasetron appears as
effective as these agents, with a similar
side effect profile. The ECG changes
noted with dolasetron are a class effect
'
but appear to be more pronounced with
dolasetron. These effects are generally
seen at higher doses and the overall

clinical implications are unclear. The
perceived equivalent doses of ondansetron
and dolasetron are 4mg and 12.5mg,
respectively for PONV. Currently, the
cost difference for the aforementioned
doses of ondansetron ($ 17 .1 0) and
do~asetron ($ 10.20) is fairly substantial.
Cost is likely to continue to be a major
factor in the selection of a 5-HT3 receptor
antagonist for formulary inclusion as all
three available agents appear to be
effective at "equivalent doses" . The
Anesthesia subcommittee has trialed
dolasetron in selected patients using a
12.5mg dose given about 15 minutes prior
to the end of the procedure. This dose
and agent have been included in the adult
Post-Operative Antiemetic
Prophylaxis/Treatment algorithm.
Therefore, the recommendation was to
approve this agent to the Formulary for
use in the adult PONV algorithm or as a
single 12.5 mg "rescue" dose . Use of
this agent in the prevention and treatment
of chemotherapy induced nausea and
vomiting will be reviewed at a future time.

ANOTHER 'CAINE' ADDED
TO THE FORMULARY
Ropivacaine (N aropin) is indicated for
production of local anesthesia or regional
anesthesia for surgery, postoperative pain
management and obstetrical procedures.
In surgical anesthesia, it is indicated for
epidural block for surgery including
cesarean section, major nerve block and
local infiltration. In acute pain
management, it is indicated for use as an
epidural continuous infusion or intermittent
bolus (e.g., postoperative pain or labor)
and local infiltration.
Ropivacaine is an amide-type local
anesthetic and an analog of bupivacaine
and mepivacaine (see Table 1). It is used

(

(

Page 17
,,

(

(

in water-soluble form as the hydrochloride
monohydrate salt. Ropivacaine is less
lipid-soluble than bupivacaine. Unlike
bupivacaine and mepivacaine which are
available as racemates, ropivacaine is
available only as the S-isomer. It appears
that the S-isomers of these local
anesthetics are responsible for greater
anesthetic activity, while the R-isomers are
responsible for greater toxicity. By
providing ropivacaine as only the Sisomer, it is thought that it will provide
greater local anesthetic potency and less
local anesthetic toxicity than the racemic
mixture.

longer duration of analgesia and more
~pid onset of motor blockade than the
0.5% concentration. All three doses
produced effective sensory blockade, and
maximal muscle weakness occurred 1 to
1. 5 hours after administration; however, at
the higher dose the intensity and duration
of motor blockade increased. The duration
of analgesia for 0.5% ropivacaine has been
estimated to be between those of 2%
mepivacaine with epinephrine and 0.5%
bupivacaine with epinephrine, while the
duration of analgesia for 0. 75%
ropivacaine is comparable to that of 0.5%
b~pivacaine with epinephrine.

Table 1: Structural classification of local
anesthetics:

CONCLUSION: Ropivacaine appears to
be an effective local anesthetic with
efficacy comparable to bupivacaine. At
equivalent doses, ropivacaine appears to
produce comparable analgesia with less
motor block than bupivacaine. This can
be advantageous in labor analgesia and
postoperative analgesia where a loss of
motor function is not desired. It has been
suggested that it may provide a safer side
effect profile than bupivicaine, especially
related to cardiotoxic effects. However,
additional large comparative studies are
needed to determine whether the difference
is significant. Currently, the cost of an
equimilligram dose of ropivacaine is twice
that of bupivacaine. The Chiefs of
Anesthesia at the MHC, 17th St. and CC
sites are expected to utilize this agent in
selected scenarios.

Anesthetic
Bup1vacame
Chloroprocaine
Etldocame
Lidocame
Mepivacame
Prilocaine
Procame
Kop1vacame
Tetracame

Amide

Ester

X
X
X
X

X
X
X
X
X

Ropivacaine has been less toxic than
bupivacaine in animal studies. The ratio
between lethal and convulsive doses is
higher with ropivacaine than with
bupivacaine, and ropivacaine is less potent
than bupivacaine at inducing cardiac
arrhythmias. After intravenous
administration to volunteers, ropivacaine
produced less central nervous system and
cardiovascular toxicity than bupivacaine.
Although less toxic than bupivacaine,
ropivacaine is more toxic than lidocaine.

(

Epidural administration of 0.5%, 0. 75%
and 1 % ropivacaine. produced similar
durations of sensory and motor blockade in
one study, while in another study epidural
ropivacaine 0. 75% and 1% demonstrated a

ADULT PONY GUIDELINES
APPROVED
·~ i·

T!t~. Anesthesia

sub-committee put the
finishing touches on an Adult PostOperative Antiemetic Prophylaxis/
Treatment algorithm. The fmal version is
attached.

ADULT POST-OPERATIVE ANTIEMETIC PROPHYLAXIS/TREATMENT GUIDELINES

Yes

Recommendations to minimize risk factors for Post Operative Nausea & Vomiting (PONV)*
-Consider anxlolytics
-Limit opioids, no nitrous oxide
-Minimize mask ventilation or pharyngeal stimulation
-Adequate pain control
-Adequate hydration

No

No

No Treabnent.
ObseJVBfor
signs/symptoms of

Yes

PONir

No

Yes
(1) High Risk Procedure
A.. Gynecological: Laproscopic, D&C/E
B. Eye (Except cataracts under MAC)
C. ENT: T&A, UPPP, Middle ear surgery
D. Mastectomy (Reconstruction)
E. Total Knee Replacement
F. General Surgery; Laparoscopic procedures
G. Plastic Surgery: Facelifts

Droperidol 0.625mg <Dolasetron 12.5 mg IV
15 min prior to end of
procedure.. <-/Dexamethasone 4-B mg IV.

Yes

Droperidol 0.625mg
30-min prior to end of procedure
+/Oolasalron 12.5 mg IV 15
minutes prior to end of
proceilure-.

No Treatment. ObseJVe
for signs/symptoms of

PONV

No

Ondanselron 4mg IV X 1
<-/- Proctilorperazlne 1·2
mg IVnM X 1 based on
patient specific needs.

No

No Treatment.
ObsBJVefor
signs/symptoms of

--

PONV.

Yes

Consull Supervising
Aneslheslologlsl.

(2) High Risk Patients:
A. History of prolonged Post-Op nausea and vomiting > 1 episode.
B. History of motion sickness
C. Obesity defined as >30% ideal body weight and premenopausal female.
D. Failed response to previous antiemetic therapy.
**if patient meets category 20 above, administer dolasetron 12.5 mg IV X 1 in
addition to droperidol.

-

--

i

ge
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REMINDERS FOR PRE-OP
VANCOMYCIN

(

L VH healthcare professionals continuously
work together to limit the spread of
vancomycin resistant enterococci (VRE).
Assisting with the appropriate use of
vancomycin is one method by which the
occurrence of VRE may be limited.
Communication with healthcare ·workers,
and review of miscellaneous patients charts
reveal several issues in need of
clarification with respect to LVH pre-op
vancomycin use. Please fmd these issues
and suggestions/clarifications for helping
to solve the issues listed below.

G~phalosporins.

Additionally, many
patients may have allergies to penicillins,
but tolerate cephalosporins without
reaction. The hypersensitivity definition
on the L VH pre-op order sheets is there to
assist in identifying patients that are the
most appropriate candidates for pre-op
vancomycin use. The CDC discourages
the use of pre-op vancomycin for
" ... Routine surgical prophylaxis other than
in a patient who has a life-threatening
reaction to beta-lactam antibiotics." (MMWR.
1994;44,RR-12:4.). LVH pre-op order sheets
suggest that vancomycin use be limited to
patients that meet the following definitions:
a)

- Alterations in infusion durations - In
order to allow for adequate infusion time,
vancomycin infusions must be initiated on
the floor prior to sending the patient to the
OR. This recommendation is part of the
LVH policy for the administration of
surgical antibiotic prophylaxis.

(

- Documentation - It is extremely important
to document drug allergies and reaction
symptoms in the patients history and on .all
order sheets. Please remember to question
patients about the allergic symptoms that
they experience when given the drug to
which they have allergies. If available,
this information may be used to limit the
number of instances where vancomycin is
the drug therapy selection. It is very
important that this information be
transferred to all order sheets, in addition
to placement in the patient history.
- Hypersensitivity definition on pre-op
order sheets. Rationale and clariflcation Many pre-op orders at L VH have cefazolin
as the surgical antibiotic of choice.
Patients may have a variety of allergic
symptoms to penicillins, and these may be
potentially cross-reactive to

(

b)

"If allergic to Penicillin/ Cephalosporin
described as hives and/or respiratory distress
and/or collapse within minutes of a dosage
of penicillin or cephalosporin."
Patients with unobtainable histories for drug
allergies or reactions

Thank you for reviewing these issues and
suggestions for practice improvement.
Thank you for continuing to work together
to .c!imit the spread of VRE. Please call
the-pharmacy at x8884 or x8886 for
questions regarding pre-op vancomycin
use.

HEPARIN INDUCED
THROMBOCYTOPENIA
DRUG THERAPY OPTIONS
ATLVH
The Therapeutics Committee approved the
formulary addition of two agents for the
management of Heparin Induced
Thrombocytopenia (HIT), to prevent
further thromboembolic complications
(TEC)- Danaparoid (Orgaran ®,
manufactured by Organon), and Lepirudin
( Refludan ®, r DNA, manufactured by
Hoechst Marion Roussel). Currently, the
LVH Therapeutics Committee is restricting
these agents to use only by Hematology/

Page20
Oncology physicians. Future alterations to
this restriction will be reported in
subsequent newsletters. This report
provides brief drug reviews for danaparoid
and lepirudin.

Danaparoid is pharmacologically
classified as a low molecular weight
heparinoid, and is a glycosaminoglycuronan composed of heparan sulfate
(84 %) , dermatan sulfate (12%) and
chondroitin sulfate (4%). In the US
danaparoid is FDA indicated only for DVT
prophylaxis following elective hip
replacement surgery, but danaparoid has
been used extensively in HIT management
in a Worldwide Compassionate Use case
series (Magnani HN. Platelets 1997;8:74-81.).
Danaparoid' s primary anticoagulant
mechanism includes action as a catalyst
inactivating factor Xa. Subsequently, the
anti-Xa effects inhibit thrombin formation,
and inhibit fibrin and thrombus generation.
This occurs with only minor effects on
platelet function and aggregability.
The activity of danaparoid is measured by
anti-Xa levels. Maximal anti-Xa activity
occurs in 2-5 hours, ·but the half life (T 1a)
for anti-Xa effects ranges from 19.2-24.5
hours in normal renal function. Renal
elimination accounts for 40-50% of drug
elimination, and the method of elimination
for the remainder of drug is unknown.
Anti-Xa level monitoring is not needed for
all patients, but is required in the
following patient populations -- > < 55kg;
> 90kg; renal or hepatic failure;
hemodialysis, hemofl1.tration. Additional
laboratory testing for danaparoid may
include checking for potential crossreactivity to HIT antibodies. Danaparoid
may have cross-reactivity with IDT
antibodies ranging from 0-20%. Clinical
experience to date indicates that
danaparoid therapy may be initiated safely

...

before cross- reactivity testing is done.
The Worldwide Compassionate Use nonblinded case series, reporting 584
evaluable episodes with 462 TEC,
represents the only published clinical· data
for the use of danaparoid in HIT therapy.
(Magnani HN. Platelets 1997;8:74-81.) In this
case series successful outcome was defmed
as: platelet recovery, controlled (TEC),
no new TEC, and no treatment withdrawal. Platelet recovery occurred in 91%,
m,d successful treatment in 93%, while 9
patients (1. 7%) had recurrent TEC during
danaparoid therapy. The authors report
only serious adverse effects from the case
series which included bleeding (3 .1 %,
only life threatening bleeds reported),
persistent reduced platelet count (2. 6%),
and skin rash (0.9%). The overall six
. week mortality was 17.1%.
There are several dosing regimens for
danaparoid, depending on the rationale for·
anticoagulation; age of the thrombus; and
r~:f.nal status. For specific dosing
information, please contact the clinical
pharmacy office (x8884), or refer to the
citation- Wilde MI, Markham A. Drugs
1997;54:903-924. Please see table below
for advantages, disadvantages, and cost
comparison to Lepirudin.
The second HIT agent added to the L VH
formulary, Lepirudin, is recombinant
hirudin, modeled from the natural productleech Hirudo medicinalis. The only US
product FDA approved for use in HIT,
~pirudin carries the FDA Indication for:
Anticoagulation in patients with HIT &
associated thromboembolic disease to
prevent further TEC. Pharmacologically
lepirudin is classified as a direct thrombin
inhibitor. The drug acts via 1:1 binding
with thrombin to inhibit thrombogenic
activity. This activity occurs unrelated to

(
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antithrombin 111, and without neutralization
by platelet factor 4. This drug alters all
thrombin dependent coagulation assays,
and exhibits dose dependent increases in
aPTT. As a result, therapy is monitored
using aPTT. The aPTT ratio goal during
lepirudin therapy is 1.5-2.5 x control.
Lepirudin acts rapidly, with a terminal half
life of 1.3 hours. The primary route of
elimination is renal. The T112 in renal
impairment may be increased up to 2 days,
necessitating extensive dosing adjustments

(

Clinical studies in HIT include two multicenter, prospective, open label, historical
control trials- HATl (Greinacher et al.
Circulation 1999;99:73-80), and HAT2
(currently published only in abstract form
and as data on me with Hoechst Marion
Roussel). For the 79 subjects in HAT1
and the 98 subjects in HAT2, study results
were as follows: Pit recovery ranged from
86% - 92%; 74-77% showed effective
aPTT response; and TEC + Death +
Amputation =18% (HAT1, n=8,3,6
respectively) vs 28% (HAT2, n=20,10,11,

Danaparoid

Lepirudin

respectively). No deaths were due to
lepirudin. In comparison with historical
controls, lepirudin showed significantly
less TEC + Death + Amputation on days
7 and 35 in HAT1, but in HAT2
differences did not reach statistical
significance. The authors noted bleeding
to be the most common adverse effect
[HATi- 32.9% had at least 1 event
(13.4% major bleeds), HAT2- 48% had
major or minor bleeding].
There are very specific guidelines for
dosing and monitoring lepirudin therapy.
Dosing depends on the presence or
absence of TEC, use of thrombolytic
therapy, and presence of renal dysfunction.
Guidelines are specific for aPTT
monitoring, resultant dosing adjustments,
and conversion to oral anticoagulants. For
more specific information on dosing and
monitoring please contact the clinical
pharmacy office (x8884). Please refer to
the. attached table for therapeutic
advantages, disadvantages, and LVH cost
compared to danaparoid.

ADVANTAGES

DISADVANIAGES

LVHCOST

-Rapid anticoagulation
-Experience in large
case series
-Lower cross-reactivity
vsLMWH
- Anti-Xa monitoring not
necessary in all patients
-More extensive clinical
experience than lepirudin
- Anti-Xa monitoring is
possible at L VH
-May have less bleeding
than lepirudin

-0-20% cross-reactivity
to HIT antibodies
- Anti-Xa monitoring using
curve calibrated w/ danaparoid
difficult from lab perspective
-No antidote for bleeding
- Tl/2 long if surgery/procedure
needed or bleeding occurs
- Tl/2 extended in renal failure
but no specific # published or
known

Dose
Day!$ Day2-$$/Week
Danap. 197-295 same13772065
Prophyl ·

-Rapid anticoagulation
-Short Tl/2
-No cross-reactivity w/
HIT antibodies
- aPTT monitoring
readily available
-Srudied as MC,
historical control data
-Only agent FDA
indicated for HIT therapy,
a potential medical legal
issue to not carry.

-?Greater bleeding risk
-Accumulation occurs in
renal impairment
-No antidote for bleeding
-? HAT2 results~ trial
unpublished to date

Danap. -1062
Inf. HIT
Therapy

5514367

LVH cost per unit= $98.36 per
750aXaU/0.6ml

Dose
Day1$
Lepir. 373
HIT w/o
TEC

Dav2-$$/Week
same2609

Lepir.

5593976

621

HIT+TEC
LVH cost per unit= $103.54 per
50 mg
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April, 1999

Symposium
Announcement

News from the Library
National Library Week is

The Sixth Annual Update on
Heart and Lung Surgety
will be held on Saturday,
April10, 1999 in theLVH
Cedar Crest Auditorium.

(

April 11th - 17th.
OVIDI.PubMed TRAINING.

To schedule one-on-one OVID (MEDLINE)
training session, call Barbara Iobst in the
Health Sciences Library at 402-8408.
Barbara can also instruct you in the use of
PubMed, a free, Web-based MEDLINE
service offered by the National Library of
Medicine (NLM). :MEDLINE can be
searched directly using PubMed.

The program will:
- Describe and discuss new procedures and
technology in cardiothoracic surgery,
- Compare off-pump beating heart versus
port-access coronary artery bypass surgery,
- Discuss the new endoscopic approach to ·
lobectomy,
- Review advanced mechanical support for
the failing heart, and
- Examine the early results on the new
stentless biological aortic valve.

Library Book Order

The Health Sciences Library is preparing its
fiscal year-end book order and is seeking
input from the medical staff. Please E-mail
Barbara lobst, Director ofLibrary Services,
with your recommendations. If you prefer
to call, her extension is 402-8408.

For more information or to register, please
contact Bonnie Schoeneberger via Email or
phone at (610) 402-1210.
·
If you plan to attend the Update, you and a

(

guest are cordially invited to attend a
cocktail reception honoring the visiting
professors on April 9, 1999 7-10 pm at the
John and Dorothy Morgan Cancer Center's
Kelly Gallagher Atrium. Please RSVP to
Bonnie Schoeneberger.

"Comprehensive Neurology," 2nd edition
Author: R Rosenberg, et al.
Call No. WL 100 C737 1998

Continuing Education:

New Books- Cedar Crest & 1-78.

New Publications - Muhlenbem Hosoital
Center.

"Hematology/Oncology Clinics ofNorth
America" Topic: "Current Therapeutic
Issues in Gynecologic Cancer" Volume 13,
No. I -February, I999

See the following calendar for grand rounds
and tumor boards.

I

Computer-Based Training <CBD:

"The Medical Clinics ofNorth America"
Topic: "Parkinson's Disease and
Parkinsonian Syndromes"
Guest Editor: M Stem, et al.
Volume 83, No.2- March, 1999.

(

CBT is replacing instructor-led classes
previously held at LVH. A proctor will be
in the room with the learner while slhe takes
the CBT, but the learner will control the
pace and objectives of the learning.

New Boolq - 17th & Chew.

Topics covered by CBT include:
Access 2.0 & 97
WindowsNT4
Word97
Excel97
PowerPoint 97
PHAMIS Lastword Inquiry only commands
E-mail GUI

"Seminars in Perinatology"
Topic: "Current and Evolving Concepts in
Preeclampsia"
Guest Editor: G. Saade
Volume 23, No. 1 -February, 1999
"Current Problems in Obstetrics,
Gynecology, and Fertility"
Topic: "Fetal Telemedicine: Its Role in
Obstetric Ultrasonography"
Guest Editor: F. Malone, et al.
Volume 22, No. 1- January/February, 1999.

CBT takes place in JDMCC, Suite 401.
From April through December 1999, there
will be two CBT sessions every Tuesday.
The morning session is 8:00 am to noon.
The afternoon session is 12:30 to 4:30 pm.
Twelve slots are available for each session

News from the Office of
Educational Technology

To register, please contact Bonnie
Schoeneberger via email or at 402-1210.
If you have questions regarding CBT, please
contact Craig Koller via email or at 4021427.

PC Basics, Windows NT/95 & Eman:
The following classes will be held at
Muhlenberg Hospital Center in the liS
Training Room off the lobby of the main
building. Please call317-4771 to register.
Registration is required.

Ally ~. concems or COfrllllerlll on articlesfrom C£DS,
pleau CGflflrct Sllllk UTfler 402-1403

PC Basics
April9 - 9-llam
April 23 - 9-llam
Windows NT/95
April9 ·- 1-3pm
April 23 - 1-3pm
Email Intro.
April16- 9-llam
April30- 9-llam
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. . . ltd l'raf• lill
Grand Round and
Tumor Board Schedule

SUNDAY

Avril

MoNDAY

WEDNESDAY

TUESDAY

THURSDAY
8 am Emergency
Medicine Grand Rounds12S1SCC, Suite 308C

FRIDAY
I 7 am GVN Tumor
BoardiOBGVN Grand
Rounds - 17 Aud

12 Noon Combined
Tumor Board- JDMCCCR1AIB
4 12 Noon CIR Tumor Board
- JDMCC - CR1 AlB

5

7 am Surglcel Grand
RIIIIIMk - CC-Aud -

1 7am OBGVN G111nd
Rounds -17 Aud

- JDMCC- CR1 AlB

12 Noon Pediatric Noon
Conf-17Aud

12 Noon Medical Grand
Rounds CC-Aud

12 Noon Brast Tumor
Board- JDMCC.. CR1 AlB

Guideline Dev- SON

D 12 Noon Pulmonary Tumor
Board - JDMCC- CR1 AlB

14 12 Noon Cancer

Committee- JDMCCCR1AIB

2

l

9 730am
Update on Heart
& Lung Surgery
CCAud

10

16

17

12 Noon 8.-t Tumor
Board- JDMCC.. CR1 AlB

lam PediatriC G111nd
Rounds- 17-Aud

12 7em Ambulatory CBn

II

7 12 Noon Gl Tumor Board

6

SATURDAY

IS 7am OBGVNG111nd
Rounda -17 Aud

12 Noon 8.-t Tumor
Board- JOMCC- CR1 AlB

7 am Surgical G111nd
Rounds- CC-Aud-

I

i

lam PediatriC G111nd
Rounds- 17-Aud
12 Noon Medical G111nd
Rounds CC-Aud

18

25

12 Noon CIR Tumor Board

- J0MCC • CR1 AlB

19 7 am Surgical Grand
Rounds- CC-Aud •

20

11

12 Noon Combined
Tumor Board- JDMCC CR1AIB

n

7em OBGVN G111nd
Rounda -17 Aud

8am PediatriC G111nd
Rounds -17-Aud

12 Noon Pediatric Noon
Conf-17Aud

12 Noon Medical Gl1lnd
Rounds CC-Aud

12 Noon Breast Tumor
Board - JDMCC. CR1 AlB

26 7 am stahler /Rex

Sym~um- CC-Aud-

8am Pediatric G111nd
Rounds - 17-Aud

17

18

12 Noon Combined
Tumor Board - JDMCC CR1AIB

19

7am OBGVN G111nd
Rounds -17 Aud

n

24

lO

12 Noon Br.at Tumor
Board- JOMCC. CR1 AlB

12 Noon Medical G111nd
Rounds CC-Aud
12 Noon Urology Tumor
Board - JDMCC - CR1
AlB

i
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Medical Staff Progress Notes
is published monthly to
inform the Medical Staffs of
Lehigh Valley Hospital and
Muhlenberg Hospital Center
and employees of important
issues concerning the
Medical Staffs.
Articles should be submitted
to Janet M. Seifert, Physician
Relations, Lehigh Valley
Hospital, Cedar Crest & 1·78,
P.O. Box 689, Allentown, PA
18105-1556, by the 15th of
each month. If you have any
questions about the
newsletter, please call Mrs.
Seifert at 402-8590.
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